Patient Capital Management 13F, Q2 2026
Samantha McLemore · quarter ending 30 June 2026 · filed 13 August 2026 · SEC CIK 1854794
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 1 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q2 2026
The 25 largest of 39 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2026 filing.
| Company | Ticker | Value | % of book | vs Q1 2026 |
|---|---|---|---|---|
| ROYALTY PHARMA PLC | $201.79M | 6.7% | unchanged | |
| CITIGROUP INC | C | $196.43M | 6.5% | unchanged |
| ALPHABET INC | GOOGL | $187.89M | 6.2% | unchanged |
| UNITEDHEALTH GROUP INC | UNH | $181.95M | 6.0% | unchanged |
| AMAZON COM INC | AMZN | $162.32M | 5.4% | +4% shares |
| NVIDIA CORPORATION | NVDA | $141.98M | 4.7% | unchanged |
| CVS HEALTH CORP | CVS | $127.81M | 4.3% | -9% shares |
| NORWEGIAN CRUISE LINE HLDGS | $127.29M | 4.2% | +5% shares | |
| QXO INC | QXO | $123.32M | 4.1% | +5% shares |
| ENERGY TRANSFER L P | ET | $116.26M | 3.9% | unchanged |
| PEOPLE INC | PPLI | $111.96M | 3.7% | -10% shares |
| PRECIGEN INC | PGEN | $108.51M | 3.6% | +7% shares |
| UNITED AIRLS HLDGS INC | UAL | $99.48M | 3.3% | unchanged |
| CROCS INC | CROX | $96.44M | 3.2% | -5% shares |
| META PLATFORMS INC | META | $96.20M | 3.2% | unchanged |
| CHIME FINL INC | CHYM | $83.61M | 2.8% | +42% shares |
| ADOBE INC | ADBE | $74.04M | 2.5% | +22% shares |
| SEADRILL LTD | $73.88M | 2.5% | -9% shares | |
| GLOBAL PMTS INC | GPN | $68.37M | 2.3% | new |
| COINBASE GLOBAL INC | COIN | $67.54M | 2.2% | +7% shares |
| FIDELITY WISE ORIGIN BITCOIN | FBTC | $62.16M | 2.1% | +244% shares |
| BIOGEN INC | BIIB | $61.30M | 2.0% | -25% shares |
| ILLUMINA INC | ILMN | $60.72M | 2.0% | -37% shares |
| GENERAL MTRS CO | GM | $48.68M | 1.6% | -15% shares |
| UBS GROUP AG | $47.27M | 1.6% | -23% shares |
What changed since Q1 2026
Against the Q1 2026 filing, Patient Capital Management opened 2 new positions, added to 9, trimmed 14, left 14 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001854794-26-000005, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.
